Latest news
RiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias - The Manila TimesThe Manila Times · Sat, 08 Aug 2026 08:04:32 GMTSafety and Efficacy of IL-10–Expressing CAR T-Cell Therapy in Relapsed or Refractory DLBCL - The ASCO PostThe ASCO Post · Mon, 03 Aug 2026 14:55:35 GMTCell Therapy Weekly: RMAT Designation for Allogeneic CAR-T - RegMedNetRegMedNet · Fri, 31 Jul 2026 21:44:43 GMTJohnson & Johnson Backs In Vivo CAR-T With a Three-Part Deal for Sail Biomedicines - BioBuzzBioBuzz · Fri, 31 Jul 2026 18:28:31 GMTJ&J secures option to acquire Sail in USD 3.5 billion in vivo CAR-T alliance - AllSciAllSci · Fri, 31 Jul 2026 13:01:13 GMTJ&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout - Pharmaceutical TechnologyPharmaceutical Technology · Fri, 31 Jul 2026 09:59:58 GMTCREATE Medicines Expands Targeted In Vivo CAR Platform Through Strategic Research Collaboration and Exclusive License Agreement with Monash University - PR NewswirePR Newswire · Fri, 31 Jul 2026 07:00:00 GMTJ&J secures $2.58bn option to buy in vivo CAR T firm Sail Biomedicines - BioXconomyBioXconomy · Fri, 31 Jul 2026 07:00:00 GMT